Zobrazeno 1 - 10
of 2 263
pro vyhledávání: '"VOSKARIDOU E."'
Publikováno v:
HemaSphere, Vol 6, Pp 58-58 (2022)
Externí odkaz:
https://doaj.org/article/1aaf4d4318ed43fb8d006abed20f1b9e
Autor:
Cappellini MD; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy., Taher AT; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon., Piga A; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy., Shah F; Department of Haematology, Whittington Health NHS Trust, London, UK., Voskaridou E; Centre of Excellence in Rare Haematological Diseases-Haemoglobinopathies, Laiko General Hospital, Athens, Greece., Viprakasit V; Siriraj Hospital, Mahidol University, Bangkok, Thailand., Porter JB; University College London Hospitals NHS Foundation Trust, London, UK., Hermine O; Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.; Imagine Institute, INSERM Unité 1163, University of Paris, Paris, France., Neufeld EJ; St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Thompson AA; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA., Tang D; Bristol Myers Squibb, Princeton, New Jersey, USA., Yucel A; Bristol Myers Squibb, Princeton, New Jersey, USA., Lord-Bessen J; Bristol Myers Squibb, Princeton, New Jersey, USA., Yu P; Evidera, Waltham, Massachusetts, USA., Guo S; Evidera, Waltham, Massachusetts, USA., Shetty JK; Bristol Myers Squibb, Princeton, New Jersey, USA., Miteva D; Bristol Myers Squibb, Princeton, New Jersey, USA., Zinger T; Bristol Myers Squibb, Princeton, New Jersey, USA., Backstrom JT; Acceleron Pharma Inc., a Subsidiary of Merck & Co., Inc., Rahway, New Jersey, USA., Oliva EN; Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy.
Publikováno v:
European journal of haematology [Eur J Haematol] 2023 Jul; Vol. 111 (1), pp. 113-124. Date of Electronic Publication: 2023 Apr 24.
Autor:
Kattamis A; First Department of Pediatrics Thalassemia Unit National and Kapodistrian University of Athens Athens Greece., Voskaridou E; Expertise Center in Rare Haematological Diseases-Haemoglobinopathies General Hospital of Athens 'Laikon' Athens Greece., Delicou S; Thalassemia and Sickle Cell Unit General Hospital of Athens 'Hippocrateion' Athens Greece., Klironomos E; Thalassemia and Sickle Cell Unit General Hospital of Heraklion 'Venizelion' Heraklion Greece., Lafiatis I; Thalassemia and Sickle Cell Unit General Hospital of Mytilene 'Vostanio' Mytilene Greece., Petropoulou F; Thalassemia Unit General Hospital of Athens 'Georgios Gennimatas' Athens Greece., Diamantidis MD; Thalassemia and Sickle Cell Disease Unit General Hospital of Larissa 'Koutlimbaneio & Triantafylleio' Larissa Greece., Lafioniatis S; Thalassemia and Sickle Cell Unit General Hospital of Volos 'Achilopouleio,' Volos Greece., Evliati L; Thalassemia and Sickle Cell Unit General Hospital of Athens 'Evaggelismos' Athens Greece., Kapsali E; Department of Hematology University Hospital of Ioannina Ioannina Greece., Karvounis-Marolachakis K; Medical Department Genesis Pharma SA Athens Greece., Timotheatou D; Medical Department Genesis Pharma SA Athens Greece., Deligianni C; Medical Department Bristol-Myers Squibb Company SA Athens Greece., Viktoratos P; Medical Department Bristol-Myers Squibb Company SA Athens Greece., Kourakli A; Department of Internal Medicine Hematology Division University General Hospital of Patras Patras Greece.
Publikováno v:
EJHaem [EJHaem] 2023 May 23; Vol. 4 (3), pp. 569-581. Date of Electronic Publication: 2023 May 23 (Print Publication: 2023).
Autor:
Piga A, Perrotta S, Gamberini MR, Voskaridou E, Melpignano A, Filosa A, Caruso V, Pietrangelo A, Longo F, Tartaglione I, Borgna-Pignatti C, Zhang X, Laadem A, Sherman ML, Attie KM.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3977::06e1978e886b8743858502883552c10d
http://hdl.handle.net/11591/404561
http://hdl.handle.net/11591/404561
BACKGROUND Patients with transfusion-dependent β-thalassemia need regular red-cell transfusions. Luspatercept, a recombinant fusion protein that binds to select transforming growth factor β superfamily ligands, may enhance erythroid maturation and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::d65fb3b1b840e3960ecd85e22afd780e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104621
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104621
Background: Regular transfusions are the gold standard therapy for β-thalassemia and are often complicated by secondary-iron overload and alloimmunization. We assessed the frequency of regulatory T cells (Tregs) and the levels of cytokines implicate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::dd76011410c7a89d071f00f01e99d960
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078803
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078803
Autor:
Habibi A; Sickle Cell Referral Center, Internal Medicine Unit, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris, U-PEC, 94000 Créteil, France.; INSERM-U955, Institut Mondor, Université Paris-Est Créteil, Team 2 Transfusion et Maladies du Globule Rouge, Laboratoire d'Excellence GR-Ex, 94000 Créteil, France., Cannas G; Edouard Herriot Hospital, 69003 Lyon, France., Bartolucci P; Sickle Cell Referral Center, Internal Medicine Unit, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris, U-PEC, 94000 Créteil, France.; INSERM-U955, Institut Mondor, Université Paris-Est Créteil, Team 2 Transfusion et Maladies du Globule Rouge, Laboratoire d'Excellence GR-Ex, 94000 Créteil, France., Voskaridou E; Thalassemia and Sickle Cell Disease Center, 'Laiko' General Hospital, 115 27 Athens, Greece., Joseph L; Biotherapy Department, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, 75610 Paris, France., Bernit E; Sickle Cell Referral Center, CHU Guadeloupe-Pôle Parents-Enfants-Hôpital Ricou, BP465, Pointe à Pitre, CEDEX, 97159 Guadeloupe, France., Gellen-Dautremer J; CHU la Milétrie, 86000 Poitiers, France., Charneau C; Basse-Terre Hospital, Basse-Terre 97109, Guadeloupe., Ngo S; Delafontaine Hospital, 93200 Saint-Denis, France., Galactéros F; Sickle Cell Referral Center, Internal Medicine Unit, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris, U-PEC, 94000 Créteil, France.; INSERM-U955, Institut Mondor, Université Paris-Est Créteil, Team 2 Transfusion et Maladies du Globule Rouge, Laboratoire d'Excellence GR-Ex, 94000 Créteil, France.
Publikováno v:
Biomedicines [Biomedicines] 2023 Feb 17; Vol. 11 (2). Date of Electronic Publication: 2023 Feb 17.
Autor:
Flevari P; Centre of Excellence in Rare Hematological Disease-Hemoglobinopathies, Laiko General Hospital, 11527 Athens, Greece., Voskaridou E; Centre of Excellence in Rare Hematological Disease-Hemoglobinopathies, Laiko General Hospital, 11527 Athens, Greece., Galactéros F; Sickle Cell Referral Center, Department of Internal Medicine, Henri-Mondor University Hospital, APHP, U-PEC, 94000 Créteil, France., Cannas G; Hospices Civils de Lyon, Edouard-Herriot Hospital, Internal Medicine, Reference Centre for Sickle-Cell Disease, Thalassemia and Other Red Blood Cell Disorders, 69003 Lyon, France., Loko G; Martinique Hospital, 97212 Martinique, France., Joseph L; Biotherapy Department, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, 75610 Paris, France., Bartolucci P; Sickle Cell Referral Center, Department of Internal Medicine, Henri-Mondor University Hospital, APHP, U-PEC, 94000 Créteil, France., Gellen-Dautremer J; Sickle Cell Referral Center, Department of Internal Medicine, Henri-Mondor University Hospital, APHP, U-PEC, 94000 Créteil, France., Bernit E; Antilles-Guyane Reference Centre for Sickle-Cell Disease, Thalassemia and Other Red Blood Cell Disorders, Pointe à Pitre, 97157 Guadeloupe, France., Charneau C; Antilles-Guyane Reference Centre for Sickle-Cell Disease, Thalassemia and Other Red Blood Cell Disorders, Pointe à Pitre, 97157 Guadeloupe, France., Habibi A; Sickle Cell Referral Center, Department of Internal Medicine, Henri-Mondor University Hospital, APHP, U-PEC, 94000 Créteil, France.
Publikováno v:
Biomedicines [Biomedicines] 2022 Dec 09; Vol. 10 (12). Date of Electronic Publication: 2022 Dec 09.
Autor:
Piga A; Department of Clinical and Biological Sciences, Turin University, Regione Gonzole, 10, Orbassano, 10043 Turin, Italy., Longo F; Department of Clinical and Biological Sciences, Turin University, Turin, Italy., Gamberini MR; Thalassemia Unit, Arcispedale S. Anna, Ferrara, Italy., Voskaridou E; Thalassemia and Sickle Cell Center, Laiko General Hospital, Athens, Greece., Ricchi P; Malattie Rare Del Globulo Rosso, AORN Cardarelli, Naples, Italy., Caruso V; ARNAS Garibaldi, Catania, Italy., Pietrangelo A; CEMEF, Medicina 2, Modena, Italy., Zhang X; Formerly Acceleron Pharma, Cambridge, MA, USA., Shetty JK; Celgene International Sàrl, Bristol-Myers Squibb Company, Boudry, Switzerland., Attie KM; Formerly Acceleron Pharma, Cambridge, MA, USA., Tartaglione I; Università della Campania 'L. Vanvitelli', Naples, Italy.
Publikováno v:
Therapeutic advances in hematology [Ther Adv Hematol] 2022 Dec 05; Vol. 13, pp. 20406207221134404. Date of Electronic Publication: 2022 Dec 05 (Print Publication: 2022).